The effect of a nutritional supplement on post prandial glucose and lipids in an adult population

Trial description: As Contac nasal spray was approved as a switch over-to-counter, it was mandatory to carry out post marketing surveillance (PMS) for a certain period and to report its result to PMDA. With this purpose, GSK has selected stores to participate in PMS of ‘Contac Nasal Spray’, and will be asking customers to fill in the questionnaire regarding efficacy and frequency of adverse effects, etc, in order to comprehend its actual usage in the market. In this way, collected information will be utilized to help develop products that ensure further safety and satisfaction of the consumers. The consumers will bring the filled questionnaire after using the nasal spray to the store from where it was purchased.